WELCOME TO JOHNS HOPKINS HEALTH ALERTS!

This free public service from Johns Hopkins Medicine helps keep you up to date on the latest breakthroughs for the most common medical conditions which prevent healthy aging. Browse all the articles via the Health Alert Topics navigation bar on the right, or read the headlines below.


Get the latest news sent straight to your Inbox. Register now for your FREE Johns Hopkins Health Alerts. Check the boxes below for all the topics you are interested in, enter your email address, and click "Send." It's fast, easy, and FREE.   Benefits of Being A Registered User

Enter your email here: (Example: yourname@domain.com)
Please send my alerts as:

We value your privacy and will never rent your email address.Already a Member? Manage your Health Alerts


Johns Hopkins Health Alert

Research Spells Good News for Prostate Cancer Patients

Comments (4)

  • Strict Diet and Lifestyle Changes May Reduce the Risk of Progression in Early Prostate Cancer

 

Men with early prostate cancer who follow a strict vegetarian diet, exercise regularly and practice stress reduction techniques may be able to lower their PSA levels and their risk of cancer progression, according to a study from the Journal of Urology. Researchers wanted to test the ability of a very low-fat diet (10 percent or less of daily calories) to slow or prevent worsening of early prostate cancer. The diet followed was a variation on the Ornish diet, originally designed by Dean Ornish, M.D., to reduce heart disease risk. The 93 study participants were men with early-stage prostate cancer who had chosen “watchful waiting” instead of active treatment for their prostate cancer. The men were randomly assigned to the Ornish program or to usual care.

During the one-year study, six men in the usual care group underwent conventional treatment because of rising PSA levels (an indication of disease progression) or evidence of progression on magnetic resonance imaging (MRI). In contrast, none of the men in the comprehensive lifestyle group required treatment. PSA levels decreased 4 percent in the lifestyle group, whereas PSA levels increased 6 percent in the usual care group. In addition, cell culture studies showed that blood from men in the lifestyle group inhibited the growth of prostate cancer cells by 70 percent, compared to 9 percent for men receiving usual care.

  • Prostate Cancer Diagnosis Usually Does Not Mean Shorter Lifespan

Good news for men diagnosed with prostate cancer from the Journal of Clinical Oncology: The vast majority of men diagnosed with prostate cancer today will live as long as their counterparts who do not have prostate cancer. This is the conclusion from an analysis of data from the Surveillance, Epidemiology, and End Results (SEER) program, a huge national database of cancer statistics.

The researchers examined five- and 10-year survival data for 183,484 men diagnosed with prostate cancer between 1990 and 2000. They found that the overall five-year survival rate for prostate cancer patients was 99 percent; 10-year survival was 95 percent. Compared with men in the general population, those with prostate cancer had an excess mortality of only 1 percent at five years and 5 percent at 10 years. The researchers noted that two-thirds of the men were diagnosed with well-differentiated or moderately differentiated localized/regional cancers. Among these men, there was no increased mortality compared to men in the general population.

Prostate cancer experts continue to debate whether widespread prostate-specific antigen (PSA) screening is responsible for lower mortality rates. However, most men diagnosed in the PSA era do not experience excess mortality. This finding should be comforting for men who are living with a prostate cancer diagnosis.

Posted in Prostate Disorders on December 14, 2006
Reviewed June 2011


Medical Disclaimer: This information is not intended to substitute for the advice of a physician. Click here for additional information: Johns Hopkins Health Alerts Disclaimer


Notify Me

Would you like us to inform you when we post new Prostate Disorders Health Alerts?

Post a Comment

Comments

Health Alerts registered users may post comments and share experiences here at their own discretion. We regret that questions on individual health concerns to the Johns Hopkins editors cannot be answered in this space.

The views expressed here do not constitute medical advice, and do not represent the position of Johns Hopkins Medicine or Remedy Health Media, LLC, which has no responsibility for any comments posted on this site.


DO the statistics hold true for those of us who have had their prostate removed surgically and their PSA is still increasing? Most of the statistics appear to be geared to those who have adopted a "Wait and See" attitude. lrdoria

Posted by: lrdoria | April 2, 2007 9:48 AM

In regard to your article about a strict diet helping control the progression of prostate cancer, could you tell me the reference in the Journal of Urology. Better still is it possible to get a copy. I am interested in finding out what are the modifications to the regular Ornish diet. Thank you, Maxx

Posted by: Maxx | May 19, 2007 1:41 PM

While I commend Dr. Ornish for his study that was published in the Journal of Urology in September 2006, the reduction of PSA after 1 year on the Vegan diet was 0.25 ng/ml while the placebo group noted a mild rise of 0.38 ng/ml. This data was modestly statistically significant but is seriously flawed by the use of Soy in the Vegan group. Soy, as most of us know, is a phytoestrogen that will have an impact on prostate cancer thereby, likely altering the PSA as well. In a corollary study that I published in the peer-reviewed Journal, Clinical Interventions in Aging (Volume 2, Number 1, 2007), I was able to show a decrease in PSA in the active study arm of 58% over a span of more than 3 years. A recent update to this data set may be viewed at www.urotoday.com. The entry was made on January 22, 2008 for interested readers. In the update, we have seen a PSA reduction of 55% representing a mean time frame of more than 4 years. I believe the reduction in inflammation of the prostate as measured by the expressed prostatic secretion (EPS) is the key to the dramatic drop in PSA. By reducing inflammation, we are effectively stabilizing,if not resolving, the disease process of non-bacterial prostatitis. The American Association of Cancer Research headed up by Johns Hopkins supports this scientific premise. R.E. Wheeler,M.D.

Posted by: prostadoc | March 9, 2008 12:52 PM

i read and re-red the 2nd paragraph on and it seems to be controdictive. but then again that could just be me. thanks

Posted by: brucerolson | March 30, 2009 4:07 PM

Post a Comment


Already a subscriber?

Login

Forgot your password?

New to Johns Hopkins Health Alerts?

Register to submit your comments.

(example: yourname@domain.com)

(800) 829-0422

Registered Users Log-in:

Forgot Password?

Become a Registered User!
It's fast and FREE!
The Benefits of Being a Registered User

Health Topic Pages

  • Health Alert
  • Special Report

What is this?

XML


Johns Hopkins' Bestsellers Prostate Disorders

Our Featured Titles:

Johns Hopkins Prostate Disorders White Paper

The Johns Hopkins Prostate Bulletin Cover

  • The Johns Hopkins Prostate Disorders Bulletin
    The Johns Hopkins Prostate Disorders Bulletin is a quarterly publication that presents the latest treatment information available on prostate cancer, enlarged prostate (BPH), and prostatitis to help you take charge of your medical care for prostate disease. Each issue is like having an in-depth consultation with a leading specialist. PLUS, subscribe now and get a special discount PLUS 5 FREE Special Reports as INSTANT PDF DOWNLOADS:
    • Special Report #1: BPH (Benign Prostatic Hyperplasia)
    • Special Report #2: Diet and Prostate Health
    • Special Report #3: Treating Overactive Bladder
    • Special Report #4: Chronic Prostatitis: New Research, Renewed Hope
    • Special Report #5: The Radical Prostatectomy

    Click here to read more or order The Johns Hopkins Prostate Disorders Bulletin.


    Related Titles:

    THE JOHNS HOPKINS PROSTATE LIBRARY


    A series of cutting-edge publications designed to address your specific prostate questions.

    • Choosing the Right Treatment for Prostae Cancer
      A must-read primer for any man recently diagnosed with prostate cancer who is looking for answers to pressing questions about treatment options. Our specialists explain in-depth: proactive surveillance, also known as expectant management ... nerve-sparing radical prostatectomy . . . radiation therapy, including EBRT, 3DCRT, IMRT, IGT, and brachytherapy. Written by Jacek L. Mostwin M.D. and colleagues at the world-renowned James Buchanan Brady Urological Institute at Johns Hopkins - the hospital and urology center ranked #1 year after year by U.S. News & World Report -- Choosing the Right Treatment for Prostate Cancer takes you step-by-step through the decision-making process to help you make informed choices.
      Read More

    Restoring Sexual Intimacy After Prostate Cancer Treatment

    The Best Treatment Strategies for BPH

    • The Best Treatment Strategies for BPH
      Written by a team of top specialists at Johns Hopkins' renowned Brady Urological Institute, this essential guide presents the latest thinking on managing benign prostatic hyperplasia (BPH) or enlarged prostate. The report answers dozens of questions from patients searching for practical, no-nonsense advice on living with BPH. It provides a thorough discussion of your surgical options when medication no longer works, weighing the pros and cons of TUNA, TUMT, and TURP. Armed with the information in this guide, you'll be able to meet with your own physician and make the right decisions in your quest for the best possible outcome.
      Read more...

    The Latest Treatments for Advanced Prostate Cancer

    • The Latest Treatments for Advanced Prostate Cancer
      If you've just received the bad news that your prostate cancer has returned, America's #1 Urology Center's specialists offer this up-to-the-minute treatment guide is designed as a detailed primer on advanced prostate cancer, so you can know all your options for dealing with this major health
      Read more...